PDB ID: 6MO7
Hetero Atom Contents
The number of atoms exceeds 100,000. So, it can not be displayed here.
Select unit:
Select hetatm:
Select chain: Sequence
Data format:
Color scheme of protein:
Structure summary
Code : | 6MO7 PDBj RCSB PDB PDBe | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Header : | transcription/transcription inhibitor | ||||||||||||
Title : | N-terminal bromodomain of human BRD2 with N-((4-(3-(N-cyclopentylsulfamoyl)-4-methylphenyl)-3-methylisoxazol-5-yl)methyl)acetamide inhibitor | ||||||||||||
Release Data : | 2019-01-23 | ||||||||||||
Compound : |
|
||||||||||||
Source : |
|
||||||||||||
Authors : | Lansdon, E.B., Newby, Z.E.R. | ||||||||||||
Keywords : | Inhibitor, epigenetic reader, bromodomain, transcription-transcription inhibitor complex | ||||||||||||
Exp. method : | X-RAY DIFFRACTION ( 1.85 Å ) | ||||||||||||
Citation : |
Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
Sperandio, D.,Aktoudianakis, V.,Babaoglu, K.
et al.
PubMed: 30606676 |
Reaction
Chain : | A, B, C |
---|---|
UniProt : | P25440 (BRD2_HUMAN) |
Reaction : | - |